ÂÜÀòÂÒÂ×

Aibek Mursalimov currently serves as a Senior Research Associate at Shoreline Biosciences, Inc., focusing on the development of iPSC-derived CAR-NK and CAR-MAC cell therapies, alongside the differentiation and expansion of iNK and iMAC cells. Previously, Aibek was a Senior Research Associate at Mitsubishi Tanabe Pharma America, specializing in iPSC-derived CAR-NK cell therapy and various related tasks including cell line generation and functional validation. Aibek's academic background includes a Master of Science degree in Molecular and Cellular Biology from Arizona State University, and extensive research experience in DNA repair mechanisms and macrophage fusion from positions at the CNRS and ASU. Aibek also holds a Master's degree in Biotechnology from al-Farabi Kazakh National University and has participated in research efforts at reputable institutions, demonstrating a solid foundation in biotechnological applications and cell biology.